German Scientists Call for Recognition of Post-Acute COVID-19 Vaccination Syndrome (PACVS) as a Medical Condition
Nikhil Prasad Fact checked by:Thailand Medical News Team Dec 07, 2024 4 days, 21 hours, 30 minutes ago
Medical News: Introduction to PACVS
German researchers from the Central Institute of Clinical Chemistry and Laboratory Diagnostics at the Medical Faculty, Heinrich Heine University, Düsseldorf, are urging global health authorities to officially recognize a chronic condition known as Post-Acute COVID-19 Vaccination Syndrome (PACVS). This condition, they argue, shares striking similarities with long COVID (PASC or post-acute sequelae of SARS-CoV-2 infection), which the World Health Organization (WHO) formally recognized as a disease in 2021. Despite its growing evidence base, PACVS remains unacknowledged, leaving many sufferers without proper medical or social support.
What Is PACVS?
PACVS is characterized by long-lasting, debilitating symptoms that emerge after SARS-CoV-2 vaccination. According to the researchers, led by Barbara Platschek and Fritz Boege, common symptoms include chronic fatigue, neurological issues like paresthesia (tingling sensations), dizziness, cardiovascular problems, and brain fog. Notably, these symptoms persist far beyond the short-term side effects typically associated with vaccination.
This Medical News report examines the findings and arguments from the researchers, highlighting why official recognition of PACVS is crucial for patients, healthcare systems, and public trust in vaccination programs.
Key Findings from the Study
The researchers conducted an in-depth review of pharmacovigilance data, clinical studies, and self-reported cases to establish the prevalence, characteristics, and potential causes of PACVS. Their findings include:
-Symptom Duration: PACVS symptoms, though similar to common vaccine side effects, last significantly longer, often for months or even years. This prolonged duration is a key differentiator.
-Prevalence Estimates: Data from occupational surveillance suggest that PACVS affects approximately 0.9% of vaccinated individuals in certain age groups, particularly young and middle-aged adults. This is significantly higher than the 0.003% prevalence derived from pharmacovigilance reports.
-Impact on Daily Life: PACVS has severe socio-economic repercussions for sufferers. Without official recognition, they struggle to access healthcare, disability support, and employment accommodations.
-Biological Markers: Alterations in blood markers, such as elevated interleukins 6 and 8, were found in PACVS patients, indicating systemic inflammation. These findings may pave the way for diagnostic tests.
Why Is PACVS Overlooked?
The researchers identify several reasons for the delayed recognition of PACVS:
-Focus on Acute Reactions: Early pharmacovigilance efforts primarily monitored acute side effects within days of vaccination. Prolonged symptoms like those in PACVS were often missed or dismissed as unrelated.
-Inconsistent Data Follow-Up: Many cases in pharmacovigilance databases were marked as “not recovered” or “reco
vering,” but systematic long-term follow-up was lacking.
-Vaccine Modifications: The composition of mRNA vaccines was altered post-authorization, potentially increasing DNA impurities. These changes, the researchers suggest, may contribute to PACVS but were not re-evaluated in new clinical trials.
The Socio-Economic Toll of PACVS
Patients with PACVS often face a double burden: debilitating symptoms and a lack of recognition from healthcare providers and insurers. Without an official diagnosis, many are dismissed as having psychosomatic conditions. This lack of validation leads to inadequate treatment and, for many, financial hardship as they are unable to work.
The study's authors emphasize that recognizing PACVS is not just a medical necessity but a social one. By acknowledging the condition, healthcare systems can implement targeted treatments and social policies to support affected individuals.
Comparison with Long COVID
PACVS and long COVID share many symptoms, including fatigue, brain fog, and cardiovascular issues. However, long COVID was rapidly recognized due to its link to SARS-CoV-2 infection. The researchers argue that the delayed recognition of PACVS stems from political and logistical factors rather than a lack of evidence. They highlight the importance of learning from the long COVID experience to develop diagnostic and treatment pathways for PACVS.
Conclusions
The call for recognizing PACVS as a medical condition is a crucial step toward addressing the needs of affected individuals. The study outlines several recommendations:
-Official Recognition: Health authorities should classify PACVS as a distinct condition, enabling access to healthcare and social support.
-Research Funding: More studies are needed to understand the condition's mechanisms, prevalence, and treatment options.
-Public Awareness: Educating the public about PACVS can reduce stigma and improve trust in vaccination programs.
Denying the existence of PACVS not only harms patients but also undermines public confidence in vaccination safety. The researchers urge policymakers to act swiftly, leveraging existing data and insights to address this emerging health challenge.
The study findings were published in the peer-reviewed journal: Vaccines.
https://www.mdpi.com/2076-393X/12/12/1378
For the latest COVID-19 Vaccine News, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/good-news-for-criminals-and-lawyers-as-new-mitigating-factor-found-study-review-validates-that-covid-19-vaccines-trigger-new-onset-psychosis
https://www.thailandmedical.news/news/covid-19-vaccines-causes-persistence-of-spike-protein-in-the-cd16-monocytes-and-makes-sars-cov-2-negative-people-sick-with-pasc-like-sickness
https://www.thailandmedical.news/news/study-explores-the-impact-of-spike-proteins-from-covid-19-mrna-vaccines-on-gut-bacteria
https://www.thailandmedical.news/news/study-by-lausanne-university-hospital-in-switzerland-finds-that-moderna-covid-19-mrna-vaccines-causes-chronic-urticaria-in-many
https://www.thailandmedical.news/news/south-korean-preprint-study-five-months-ago-warns-that-covid-19-mrna-vaccines-can-cause-a-variety-of-blood-disorders-including-aplastic-anemia
Share
Tweet
Share
